Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cerebrovascular Disorders

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 98 articles:
HTML format
Text format



Single Articles


    March 2017

  1. Correction to: Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
    Circulation. 2017;135:e646.
    PubMed     Text format    


  2. LINDNER SM, Fordyce CB, Hellkamp AS, Lokhnygina Y, et al
    Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atria
    Circulation. 2017;135:1001-1003.
    PubMed     Text format    


    February 2017
  3. YOUNG LH, Viscoli CM, Curtis JP, Inzucchi SE, et al
    Cardiac Outcomes After Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance Without Diabetes.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024863.
    PubMed     Text format     Abstract available



  4. Correction to: Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Circulation. 2017;135:e48.
    PubMed     Text format    


  5. QUINLAN DJ, Eikelboom JW, Hart RG
    Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients?
    Circulation. 2017;135:656-658.
    PubMed     Text format    


  6. DUFOUIL C, Beiser AS, McClure LA, Wolf PA, et al
    A Revised Framingham Stroke Risk Profile to Reflect Temporal Trends.
    Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.115.021275.
    PubMed     Text format     Abstract available


    January 2017
  7. BENJAMIN EJ, Blaha MJ, Chiuve SE, Cushman M, et al
    Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
    Circulation. 2017 Jan 25. pii: CIR.0000000000000485.
    PubMed     Text format    


  8. XIAN Y, Federspiel JJ, Hernandez AF, Laskowitz D, et al
    Use of Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Before Stroke.
    Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.116.023940.
    PubMed     Text format     Abstract available


  9. OVBIAGELE B, Wang J, Johnston SC, Wang A, et al
    Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.
    Circulation. 2017;135:315-316.
    PubMed     Text format    


  10. NIELSEN PB, Lip GY
    Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation.
    Circulation. 2017;135:220-223.
    PubMed     Text format    


  11. ALBERTS MJ
    Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator: More Proof That Time Is Brain.
    Circulation. 2017;135:140-142.
    PubMed     Text format    


  12. WANG W, Jiang B, Sun H, Ru X, et al
    Prevalence, Incidence and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480,687 Adults.
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.025250.
    PubMed     Text format     Abstract available


  13. SIMON T, Danchin N
    Clinical Impact of Pharmacogenomics of Clopidogrel in Stroke.
    Circulation. 2017;135:34-37.
    PubMed     Text format    


    December 2016
  14. SCHWAMM LH, Chumbler N, Brown E, Fonarow GC, et al
    Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
    Circulation. 2016 Dec 20. pii: CIR.0000000000000475.
    PubMed     Text format     Abstract available


  15. BIVARD A, Huang X, McElduff P, Levi CR, et al
    The Impact of CT Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke. Analysis of Two Randomized Controlled Trials.
    Circulation. 2016 Dec 13. pii: CIRCULATIONAHA.116.022582.
    PubMed     Text format     Abstract available


    November 2016
  16. MELDUNI RM, Schaff HV, Lee HC, Gersh BJ, et al
    Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score Matched Analysis of 10,633 Patients.
    Circulation. 2016 Nov 30. pii: CIRCULATIONAHA.116.021952.
    PubMed     Text format     Abstract available


  17. GIBSON CM, Chi G, Halaby R, Korjian S, et al
    Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025427.
    PubMed     Text format     Abstract available


  18. MENON BK, Hill MD, Goyal M
    Response by Menon et al to Letter Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e406-e407.
    PubMed     Text format    


  19. VENEMA E, Lingsma HF, Dippel DW
    Letter by Venema et al Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e404-e405.
    PubMed     Text format    


  20. SHI L, Zhang D, Chen L, Truong KD, et al
    "Weekend Effect" or "Saturday Effect"? An Analysis of Hospital Mortality for Patients With Ischemic Stroke in South Carolina.
    Circulation. 2016;134:1510-1512.
    PubMed     Text format    


  21. KIM JT, Fonarow GC, Smith EE, Reeves MJ, et al
    Treatment with TPA in the "Golden Hour" and the Shape of the 4.5 Hour Time-Benefit Curve in the National US Get With The Guidelines-Stroke Population.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023336.
    PubMed     Text format     Abstract available


  22. PAN Y, Chen W, Xu Y, Yi X, et al
    Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-analysis.
    Circulation. 2016 Nov 2. pii: CIRCULATIONAHA.116.024913.
    PubMed     Text format     Abstract available


  23. HALPERIN JL, Savino JA 3rd
    Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End
    Circulation. 2016;134:e391-e392.
    PubMed     Text format    


  24. NIELSEN PB, Lip GY
    Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
    Circulation. 2016;134:e389-e390.
    PubMed     Text format    


  25. ASINGER RW, Shroff GR, Herzog CA
    Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patie
    Circulation. 2016;134:e387-e388.
    PubMed     Text format    


    October 2016
  26. QUINN GR, Severdija ON, Chang Y, Singer DE, et al
    Wide Variation in Reported Rates of Stroke Across Cohorts of Patients with Atrial Fibrillation.
    Circulation. 2016 Oct 31. pii: CIRCULATIONAHA.116.024057.
    PubMed     Text format     Abstract available


  27. YANAGAWA B, Pettersson GB, Habib G, Ruel M, et al
    Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Practical Recommendations for Clinicians.
    Circulation. 2016;134:1280-1292.
    PubMed     Text format     Abstract available


    September 2016
  28. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e230-1.
    PubMed     Text format    


  29. YANG X, An R, Xu Y
    Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e228-9.
    PubMed     Text format    


  30. CHAN PH, Siu CW
    Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e226-7.
    PubMed     Text format    


    August 2016
  31. BONACA MP, Goto S, Bhatt DL, Steg PG, et al
    Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-T
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024637.
    PubMed     Text format     Abstract available


  32. OLDGREN J, Hijazi Z, Lindback J, Alexander JH, et al
    Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Circulation. 2016 Aug 28. pii: CIRCULATIONAHA.116.022802.
    PubMed     Text format     Abstract available


  33. BRAUN LT, Grady KL, Kutner JS, Adler E, et al
    Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association.
    Circulation. 2016 Aug 8. pii: CIR.0000000000000438.
    PubMed     Text format     Abstract available


  34. LIP GY
    Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e30-1.
    PubMed     Text format    


    July 2016
  35. PERALTA CA, McClure LA, Scherzer R, Odden MC, et al
    Response by Peralta et al to Letter Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Stroke
    Circulation. 2016;134:e26-7.
    PubMed     Text format    


  36. MEZUE K, Puri R, Rangaswami J
    Letter by Mezue et al Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Rando
    Circulation. 2016;134:e24-5.
    PubMed     Text format    


  37. TANG SY, Monslow J, R Grant G, Todd L, et al
    Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
    Circulation. 2016;134:328-38.
    PubMed     Text format     Abstract available


  38. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


  39. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e7-8.
    PubMed     Text format    


  40. IMPRIALOS K, Boutari C, Stavropoulos K
    Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e5-6.
    PubMed     Text format    


  41. BOUATOU Y, El Biali M, Samer CF
    Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e3-4.
    PubMed     Text format    


  42. HERRMANN HC, Thourani VH, Kodali SK, Makkar RR, et al
    One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Circulation. 2016;134:130-40.
    PubMed     Text format     Abstract available


  43. HIJAZI Z, Wallentin L
    Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
    Circulation. 2016;134:48-51.
    PubMed     Text format    


  44. FORDYCE CB, Hellkamp AS, Lokhnygina Y, Lindner SM, et al
    On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
    Circulation. 2016;134:37-47.
    PubMed     Text format     Abstract available


    June 2016
  45. MENON BK, Sajobi TT, Zhang Y, Rempel JL, et al
    Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial.
    Circulation. 2016;133:2279-86.
    PubMed     Text format     Abstract available


    May 2016
  46. SACCO RL, Roth GA, Reddy KS, Arnett DK, et al
    The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Circulation. 2016 May 9. pii: CIR.0000000000000395.
    PubMed     Text format     Abstract available


  47. KEHREL BE, Fender AC
    Resolving Thromboinflammation in the Brain After Ischemic Stroke?
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.116.022858.
    PubMed     Text format     Abstract available


  48. VITAL SA, Becker F, Holloway PM, Russell J, et al
    Fpr2/ALX Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.115.020633.
    PubMed     Text format     Abstract available


  49. NAYOR M, Vasan RS
    Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.
    Circulation. 2016;133:1795-806.
    PubMed     Text format     Abstract available


    April 2016
  50. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    PubMed     Text format    


  51. SAVINO JA 3RD, Halperin JL
    Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2 DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum.
    Circulation. 2016;133:1504-11.
    PubMed     Text format    


  52. LIP GY, Nielsen PB
    Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke.
    Circulation. 2016;133:1498-503.
    PubMed     Text format    


  53. BLUMENTHAL JA, Sherwood A, Smith PJ, Watkins L, et al
    Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial.
    Circulation. 2016;133:1341-50.
    PubMed     Text format     Abstract available


    March 2016
  54. HARTLEY A, Marshall DC, Salciccioli JD, Sikkel MB, et al
    Trends in Mortality from Ischaemic Heart Disease and Cerebrovascular Disease in Europe: 1980-2009.
    Circulation. 2016 Mar 22. pii: CIRCULATIONAHA.115.018931.
    PubMed     Text format     Abstract available


  55. KOVESDY CP, Norris KC, Boulware LE, Lu JL, et al
    Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans".
    Circulation. 2016;133:e453.
    PubMed     Text format    


  56. KULLER LH, Neaton JD
    Letter by Kuller and Neaton Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans".
    Circulation. 2016;133:e452.
    PubMed     Text format    


  57. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    The Use of Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with History of Intra-Cranial Hemorrhage.
    Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.115.019794.
    PubMed     Text format     Abstract available


  58. BONACA MP, Gutierrez JA, Creager MA, Scirica BM, et al
    Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Inf
    Circulation. 2016;133:997-1005.
    PubMed     Text format     Abstract available


  59. HOFMANN BOWMAN MA, Liao JK
    Relative Lack of Culprit and Obstructive Coronary Lesions in Patients with Acute Ischemic Stroke and Elevated Cardiac Troponin.
    Circulation. 2016 Mar 1. pii: CIRCULATIONAHA.116.021795.
    PubMed     Text format     Abstract available


  60. MOCHMANN HC, Scheitz JF, Petzold GC, Haeusler KG, et al
    Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac Troponin: The TRoponin ELevation in Acute Ischemic Stroke (TRELAS) Study.
    Circulation. 2016 Mar 1. pii: CIRCULATIONAHA.115.018547.
    PubMed     Text format     Abstract available


    February 2016
  61. ALFREDSSON J, Stebbins A, Brennan JM, Matsouaka R, et al
    Gait Speed Predicts 30-Day Mortality Following Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Circulation. 2016 Feb 26. pii: CIRCULATIONAHA.115.020279.
    PubMed     Text format     Abstract available


  62. SHIKANY JM, Safford MM, Newby PK, Durant RW, et al
    Response to Letter Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".
    Circulation. 2016;133:e416.
    PubMed     Text format    


  63. ARCHER E
    Letter by Archer Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".
    Circulation. 2016;133:e415.
    PubMed     Text format    


  64. ECKEL RH, Hokanson JE
    The Prediction of Atherosclerotic Cardiovascular Disease in Type 1 Diabetes: Do We Just Stop Here?
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.116.021654.
    PubMed     Text format     Abstract available


  65. VISTISEN D, Andersen GS, Hansen CS, Hulman A, et al
    Prediction of First Cardiovascular Disease Event in Type 1 Diabetes: The Steno T1 Risk Engine.
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.115.018844.
    PubMed     Text format     Abstract available


  66. SUMNER JA, Kubzansky LD, Elkind MS, Roberts AL, et al
    Response to Letter Regarding Article, "Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women".
    Circulation. 2016;133:e401-2.
    PubMed     Text format    


  67. DURMAZ O, Kucuk U, Olgun Kucuk H
    Letter by Durmaz et al Regarding Article, "Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women".
    Circulation. 2016;133:e400.
    PubMed     Text format    


  68. OPARIL S
    SPS3 Evidence Supports Intensive Blood Pressure Control.
    Circulation. 2016;133:552-4.
    PubMed     Text format    


  69. TONELLI M, Karumanchi SA, Thadhani R
    Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.
    Circulation. 2016;133:518-36.
    PubMed     Text format     Abstract available


    January 2016
  70. ELKIND MS, Hills NK, Glaser CA, Lo WD, et al
    Herpesvirus Infections and Childhood Arterial Ischemic Stroke: Results of the VIPS Study.
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.115.018595.
    PubMed     Text format     Abstract available


  71. GROSE C
    Biological Plausibility of a Link Between Arterial Ischemic Stroke and Infection with Varicella-Zoster Virus or Herpes Simplex Virus.
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.116.021459.
    PubMed     Text format     Abstract available


  72. MOZAFFARIAN D, Benjamin EJ, Go AS, Arnett DK, et al
    Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
    Circulation. 2016;133:447-54.
    PubMed     Text format    


  73. PERALTA CA, McClure LA, Scherzer R, Odden MC, et al
    The Effect of Intensive vs. Usual Blood Pressure Control on Kidney Function Among Persons With Prior Lacunar Stroke: A Post-Hoc Analysis of the SPS3 Randomized Trial.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.019657.
    PubMed     Text format     Abstract available


  74. BARIK R
    Letter by Barik Regarding Article, "Now You See It, Now You Don't?".
    Circulation. 2016;133:e20.
    PubMed     Text format    


  75. POLLACK CV JR
    Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
    Circulation. 2016;133:e18-9.
    PubMed     Text format    


  76. TRAN KA, Zhang X, Predescu D, Huang X, et al
    Endothelial beta-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.
    Circulation. 2016;133:177-86.
    PubMed     Text format     Abstract available


    December 2015
  77. PATEL MR, Piccini JP
    The Need to Evaluate Net Clinical Effect of Stroke Prevention Therapy in Patients with End Stage Renal Disease and Atrial Fibrillation.
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.020378.
    PubMed     Text format     Abstract available


  78. SHIH CJ, Ou SM, Chao PW, Kuo SC, et al
    Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.018294.
    PubMed     Text format     Abstract available


  79. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Circulation. 2015 Dec 16. pii: CIRCULATIONAHA.115.018544.
    PubMed     Text format     Abstract available


  80. MOZAFFARIAN D, Benjamin EJ, Go AS, Arnett DK, et al
    Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
    Circulation. 2015 Dec 16. pii: CIR.0000000000000350.
    PubMed     Text format    


  81. ABDUL-RAHIM AH, Perez AC, Fulton RL, Jhund PS, et al
    Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopr
    Circulation. 2015;132:e358.
    PubMed     Text format    


  82. LIN GM, Hung Y, Li YH
    Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sop
    Circulation. 2015;132:e357.
    PubMed     Text format    


    November 2015
  83. LANZ J, Brophy JM, Therrien J, Kaouache M, et al
    Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk and Predictors.
    Circulation. 2015 Nov 23. pii: CIRCULATIONAHA.115.011241.
    PubMed     Text format     Abstract available


  84. WHITLOCK RP, Healey JS, Holmes DR
    Response to Letter Regarding Article, "Left Atrial Appendage Occlusion Debate Revisited".
    Circulation. 2015;132:e230.
    PubMed     Text format    


  85. SALZBERG SP, Emmert MY
    Letter by Salzberg and Emmert Regarding Article, "Left Atrial Appendage Occlusion Debate Revisited".
    Circulation. 2015;132:e229.
    PubMed     Text format    


  86. SOARES-MIRANDA L, Siscovick DS, Psaty BM, Longstreth WT Jr, et al
    Physical Activity and Risk of Coronary Heart Disease and Stroke in Older Adults: The Cardiovascular Health Study.
    Circulation. 2015 Nov 4. pii: CIRCULATIONAHA.115.018323.
    PubMed     Text format     Abstract available


  87. KLEINMAN ME, Brennan EE, Goldberger ZD, Swor RA, et al
    Part 5: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2015;132.
    PubMed     Text format    


    October 2015
  88. SINGLETARY EM, Zideman DA, De Buck ED, Chang WT, et al
    Part 9: First Aid: 2015 International Consensus on First Aid Science With Treatment Recommendations.
    Circulation. 2015;132.
    PubMed     Text format    


  89. AGBANI EO, van den Bosch MT, Brown E, Williams CM, et al
    Coordinated Membrane Ballooning and Procoagulant Spreading in Human Platelets.
    Circulation. 2015;132:1414-24.
    PubMed     Text format     Abstract available


    September 2015
  90. JARRETT H, Zack CJ, Aggarwal V, Lakhter V, et al
    Impact of Institutional Volume on Outcomes of Catheter Directed Thrombolysis in the Treatment of Acute Proximal Deep Vein Thrombosis: A 6-Year US Experience (2005-2010).
    Circulation. 2015;132:1127-35.
    PubMed     Text format     Abstract available


  91. KOVESDY CP, Norris KC, Boulware LE, Lu JL, et al
    Association of Race with Mortality and Cardiovascular Events in a Large Cohort of US Veterans.
    Circulation. 2015 Sep 18. pii: CIRCULATIONAHA.114.015124.
    PubMed     Text format     Abstract available


  92. KREBS-SMITH SM, Subar AF, Reedy J
    Examining Dietary Patterns in Relation to Chronic Disease: Matching Measures and Methods to Questions of Interest.
    Circulation. 2015;132:790-3.
    PubMed     Text format    


    August 2015
  93. CAPLAN LR
    Microbleeds.
    Circulation. 2015;132:479-80.
    PubMed     Text format    


    July 2015
  94. GOLDBERGER JJ, Arora R, Green D, Greenland P, et al
    Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.
    Circulation. 2015;132:278-91.
    PubMed     Text format     Abstract available


  95. LEWIS TT
    Trauma and Posttraumatic Stress Disorder: Emerging Risk Factors for Cardiovascular Disease in Women?
    Circulation. 2015;132:227-9.
    PubMed     Text format    


    June 2015
  96. SUMNER JA, Kubzansky LD, Elkind MS, Roberts AL, et al
    Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women.
    Circulation. 2015 Jun 29. pii: CIRCULATIONAHA.114.014492.
    PubMed     Text format     Abstract available


  97. AVEZUM A, Lopes RD, Schulte PJ, Lanas F, et al
    Apixaban Compared with Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the ARISTOTLE Trial.
    Circulation. 2015 Jun 23. pii: CIRCULATIONAHA.114.014807.
    PubMed     Text format     Abstract available


    May 2015
  98. SELVIN E, Rawlings AM, Lutsey P, Maruthur N, et al
    Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Circulation. 2015 May 28. pii: CIRCULATIONAHA.115.015415.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: